Info@ThinkPinkRocks.org

Patients Receiving Kyprolis Lived Twice as Long without Disease Progression

Read More:
Kyprolis demonstrates superiority over velcade in patients with relapsed multiple myeloma in head-to-head endeavor trial

Scroll to Top